120 related articles for article (PubMed ID: 20075437)
1. Persistent alpha-Klotho (a-Kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism.
Ohkido I; Yokoyama K; Imura A; Utsunomiya Y; Hosoya T; Nabeshima Y
Nephrol Dial Transplant; 2010 Mar; 25(3):1007-8; author reply 1008-9. PubMed ID: 20075437
[No Abstract] [Full Text] [Related]
2. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
Yan J; Jingbo C; Wang D; Xie S; Yuan L; Zhong X; Hao L
Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987
[TBL] [Abstract][Full Text] [Related]
3. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
[TBL] [Abstract][Full Text] [Related]
4. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
5. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
[TBL] [Abstract][Full Text] [Related]
6. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
Drüeke TB
Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
8. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
Lafage-Proust MH
Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
[TBL] [Abstract][Full Text] [Related]
9. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
Chen XJ; Chen X; Wu WJ; Zhou Q; Gong XH; Shi BM
J Cell Physiol; 2018 Sep; 233(9):7092-7102. PubMed ID: 29633272
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.
Ritter CS; Zhang S; Delmez J; Finch JL; Slatopolsky E
Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955
[TBL] [Abstract][Full Text] [Related]
11. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease.
Kawakami K; Takeshita A; Furushima K; Miyajima M; Hatamura I; Kuro-O M; Furuta Y; Sakaguchi K
Sci Rep; 2017 Jan; 7():40534. PubMed ID: 28094278
[TBL] [Abstract][Full Text] [Related]
12. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
Albuquerque RFC; Carbonara CEM; Martin RCT; Dos Reis LM; do Nascimento CP; Arap SS; Moysés RMA; Jorgetti V; Montenegro FLM; de Oliveira RB
Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor MafB may play an important role in secondary hyperparathyroidism.
Morito N; Yoh K; Usui T; Oishi H; Ojima M; Fujita A; Koshida R; Shawki HH; Hamada M; Muratani M; Yamagata K; Takahashi S
Kidney Int; 2018 Jan; 93(1):54-68. PubMed ID: 28964572
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of secondary hyperparathyroidism.
Silver J
Nephrol Dial Transplant; 2000; 15 Suppl 5():2-7. PubMed ID: 11073267
[No Abstract] [Full Text] [Related]
16. Atypical spindle cell lesions in secondary parathyroid hyperplasia.
Masuda A; Nishikawa T; Yamamoto T; Aiba M; Kobayashi M
Histopathology; 2008 Feb; 52(3):402-4. PubMed ID: 18269591
[No Abstract] [Full Text] [Related]
17. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
[TBL] [Abstract][Full Text] [Related]
18. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of serum Bio-intact PTH (1-84) and parathyroid gland size in hemodialysed patients].
Inaba M; Imanishi Y; Ueda M; Cho H; Tahara H; Ishimura E; Nishizawa Y; Yamakawa T; Okuno S
Clin Calcium; 2005 Sep; 15 Suppl 1():64-6; discussion 66-7. PubMed ID: 16272632
[TBL] [Abstract][Full Text] [Related]
20. KLOTHO methylation is linked to uremic toxins and chronic kidney disease.
Young GH; Wu VC
Kidney Int; 2012 Apr; 81(7):611-2. PubMed ID: 22419041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]